$0.6644
-0.08-10.81%
At close: -
$0.6650
0.000600.09%
After Hours: Jan 10, 7:56 PM EDT
Comments
Loading...
Unicycive Therapeutics (NASDAQ:UNCY) Stock, Earnings Estimates, EPS, And Revenue
Unicycive Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-0.050
Quarterly Revenue
$0
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Unicycive Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Unicycive Therapeutics (UNCY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $-0.05 | $-0.15 | 66.7 % |
| Q2 | 2024-08-14 | $-0.15 | $-0.19 | 21.1 % |
| Q1 | 2024-05-13 | $-0.61 | $-0.15 | -306.7 % |
| Q4 | 2024-03-28 | $-0.22 | $-0.17 | -29.4 % |
Unicycive Therapeutics (UNCY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2023-05-16 | $0 | $370.00K | -100.0 % |
FAQ
When is Unicycive Therapeutics (NASDAQ:UNCY) reporting earnings?
Unicycive Therapeutics (UNCY) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Unicycive Therapeutics (NASDAQ:UNCY)?
The Actual EPS was $-0.05, which beat the estimate of $-0.15.
What were Unicycive Therapeutics’s (NASDAQ:UNCY) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.